ATE490782T1 - Chimäre vakzine-antigene gegen das klassische schweinefieber-virus - Google Patents

Chimäre vakzine-antigene gegen das klassische schweinefieber-virus

Info

Publication number
ATE490782T1
ATE490782T1 AT07711102T AT07711102T ATE490782T1 AT E490782 T1 ATE490782 T1 AT E490782T1 AT 07711102 T AT07711102 T AT 07711102T AT 07711102 T AT07711102 T AT 07711102T AT E490782 T1 ATE490782 T1 AT E490782T1
Authority
AT
Austria
Prior art keywords
fever virus
swine fever
vaccine antigens
antigens against
chimeric vaccine
Prior art date
Application number
AT07711102T
Other languages
English (en)
Inventor
Alonso Jorge Toledo
Ramos Oliberto Sanchez
Valle Maritza Barrera
Baile Nancy Figueroa
Carratala Yanet Prieto
Molta Maria Rodroeguez
Lepoureau Maria Froeas
Nordelo Carlos Borroto
Original Assignee
Ct Ingenieria Genetica Biotech
Ct Nac De Sanidad Agropecuaria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech, Ct Nac De Sanidad Agropecuaria filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE490782T1 publication Critical patent/ATE490782T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Fiber Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT07711102T 2006-02-28 2007-02-28 Chimäre vakzine-antigene gegen das klassische schweinefieber-virus ATE490782T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20060052A CU23544A1 (es) 2006-02-28 2006-02-28 Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
PCT/CU2007/000008 WO2007098717A2 (es) 2006-02-28 2007-02-28 Antígenos vacunales quiméricos contra el virus de la peste porcina clásica

Publications (1)

Publication Number Publication Date
ATE490782T1 true ATE490782T1 (de) 2010-12-15

Family

ID=38279009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07711102T ATE490782T1 (de) 2006-02-28 2007-02-28 Chimäre vakzine-antigene gegen das klassische schweinefieber-virus

Country Status (17)

Country Link
US (1) US8409562B2 (de)
EP (1) EP1994943B1 (de)
JP (1) JP5190383B2 (de)
KR (1) KR101506979B1 (de)
CN (2) CN101426525A (de)
AR (1) AR059648A1 (de)
AT (1) ATE490782T1 (de)
BR (1) BRPI0708354B1 (de)
CA (1) CA2638830C (de)
CL (1) CL2007000529A1 (de)
CU (1) CU23544A1 (de)
DE (1) DE602007011042D1 (de)
ES (1) ES2357563T3 (de)
HK (1) HK1219052A1 (de)
MX (1) MX2008011144A (de)
RU (1) RU2406534C2 (de)
WO (1) WO2007098717A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI362416B (en) * 2008-07-31 2012-04-21 Mao Xing Biolog Technology Co Ltd Yeast expressed classical swine fever virus glycoprotein e2 and use thereof
ES2784189T3 (es) 2009-03-27 2020-09-23 Academia Sinica Métodos y composiciones para la inmunización contra virus
WO2017195919A1 (ko) * 2016-05-12 2017-11-16 주식회사 바이오앱 식물 유래의 돼지 열병 백신용 조성물 및 이의 제조방법
JP7391997B2 (ja) * 2019-04-25 2023-12-05 アグリカルチュラル テクノロジー リサーチ インスティテュート 豚熱ウイルス感染を予防するための組換えタンパク質、それを含む組成物及び細胞
GB201910794D0 (en) * 2019-07-29 2019-09-11 Pirbright Inst Vaccine
CU20210070A7 (es) * 2021-08-20 2023-03-07 Ct Ingenieria Genetica Biotecnologia Antígenos quiméricos para el control de coronavirus y composiciones que los comprenden
CN114835822B (zh) * 2022-04-22 2022-11-04 浙江洪晟生物科技股份有限公司 猪瘟病毒的多聚体疫苗及其制备方法
CN118126140A (zh) * 2023-04-10 2024-06-04 浙江省农业科学院 一种表达猪瘟病毒e2蛋白的重组伪狂犬病毒株及应用
WO2024235368A1 (es) * 2023-05-18 2024-11-21 Centro De Ingeniería Genética Y Biotecnología Composicion vacunal contra el virus de la peste porcina africana
CU20230025A7 (es) * 2023-05-18 2024-12-09 Ct Ingenieria Genetica Biotecnologia Formulación para la inmunización de cerdos por la vía oral

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542225A (en) * 1984-08-29 1985-09-17 Dana-Farber Cancer Institute, Inc. Acid-cleavable compound
ZA901719B (en) 1989-03-19 1991-01-30 Akzo Nv Hog cholera virus vaccine and diagnostics
US5651972A (en) 1989-04-21 1997-07-29 University Of Florida Research Foundation, Inc. Use of recombinant swine poxvirus as a live vaccine vector
EP0924298A1 (de) 1997-12-18 1999-06-23 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Proteinexpression in Baculovirus-vektor Expressionsystemen
FR2804028B1 (fr) 2000-01-21 2004-06-04 Merial Sas Vaccins adn ameliores pour animaux de rente
WO2001083737A2 (en) 2000-05-03 2001-11-08 University Of Guelph Porcine adenovirus type 5 vector and vaccine
RU2183972C2 (ru) 2000-07-13 2002-06-27 ВНИИ ветеринарной вирусологии и микробиологии Способ получения высокоактивной специфической к вирусу классической чумы свиней сыворотки крови свиней
CN1338309A (zh) 2000-08-10 2002-03-06 清华大学 一种合成肽猪瘟疫苗及其制备方法
RU2182495C1 (ru) 2001-05-03 2002-05-20 Федеральное государственное учреждение Всероссийский научно-исследовательский институт защиты животных Вирусвакцина против классической чумы свиней
US20040096457A1 (en) * 2001-12-11 2004-05-20 Huber Brigitte T Treatment and prevention of ebv infection and ebv-associated disorders
CU23102A1 (es) 2002-10-21 2005-12-20 Ct Ingenieria Genetica Biotech Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos
US7183384B2 (en) * 2003-03-06 2007-02-27 A & G Pharmaceutical, Inc. Monoclonal antibody 7H11 reactive with human cancer
EP1522585A1 (de) * 2003-10-09 2005-04-13 Plant Research International B.V. Chimäre Trägermoleküle zur Produktion von Impfstoffen, die durch die Schleimhaut aufgenommen werden

Also Published As

Publication number Publication date
AR059648A1 (es) 2008-04-16
CA2638830C (en) 2015-04-14
WO2007098717A3 (es) 2007-11-01
JP2009528304A (ja) 2009-08-06
ES2357563T3 (es) 2011-04-27
KR101506979B1 (ko) 2015-03-30
DE602007011042D1 (de) 2011-01-20
KR20080111023A (ko) 2008-12-22
CN105214081A (zh) 2016-01-06
CU23544A1 (es) 2010-06-17
CL2007000529A1 (es) 2008-01-18
EP1994943A2 (de) 2008-11-26
EP1994943B1 (de) 2010-12-08
CA2638830A1 (en) 2007-09-07
JP5190383B2 (ja) 2013-04-24
RU2008138536A (ru) 2010-04-10
US20090304633A1 (en) 2009-12-10
WO2007098717A2 (es) 2007-09-07
CN101426525A (zh) 2009-05-06
US8409562B2 (en) 2013-04-02
BRPI0708354B1 (pt) 2016-04-19
RU2406534C2 (ru) 2010-12-20
MX2008011144A (es) 2009-01-26
BRPI0708354A2 (pt) 2011-05-24
HK1219052A1 (zh) 2017-03-24

Similar Documents

Publication Publication Date Title
HUS2200002I1 (hu) Immunogén készítmény
ATE490782T1 (de) Chimäre vakzine-antigene gegen das klassische schweinefieber-virus
DK1959991T3 (da) Terapeutisk vaccine
AR058706A1 (es) Vacuna
DK2049559T3 (da) Forbedrede HPV vacciner
ATE462445T1 (de) Prrs-impfstoffe
EP2062246A4 (de) Impfstoffe gegen chimärische viren
DK1957528T3 (da) Nukleotid-vaccine
ZA200810285B (en) A novel virulence determinant within the E2 structural glycoproptein of Classical Swine Fever Virus
DK1858917T3 (da) Varicella-zoster-virus-vaccine
DK1926496T3 (da) PCV-2-vaccine
DK2068918T4 (da) Vaccinesammensætning omfattende syntetisk adjuvant
EP1966530A4 (de) Erwärmte verbindung
EP1773403A4 (de) Virale adjuvanzien
DK1991564T3 (da) Virosomlignende vesikler omfattende gp41-afledte antigener
MA28609B1 (fr) Vaccins
BRPI0809600A2 (pt) vírus atenuado útil para vacinas
PL2465864T3 (pl) Szczepionki z peptydem pochodzącym z Eph4
EP2198016A4 (de) Adeno-assoziierte schweineviren
BRPI0811021A2 (pt) Peptídeos e vacinas de tem8 compreendendo os mesmos
BRPI0914782A2 (pt) peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
MA28885B1 (fr) vaccins
EP2144924A4 (de) Fusionsproteinimpfstoff
BRPI0810865A2 (pt) antígenos de tripanossoma, composições vacinais, e métodos relacionados
MA28639B1 (fr) Vaccins

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties